James J. Lah - Concepedia

Author

James J. Lah

Also Known As

Alex Fedorov, Allan I Levey, Allan I. Levey, Allan L. Levey, Allan Levey, Auman, Courtney M., C. Brand, Dana Mathews, Edward Coleman, F.M. LaFerla

517

Publications

39.5K

Citations

H-Index

164

Concepts

All Affiliations

Emory University Rush University Medical Center University of Pennsylvania Johns Hopkins University Icahn School of Medicine at Mount Sinai

About

James J. Lah is an author at Emory University specializing in medicine, neuroscience, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	74	7.3K
2	Natural Sciences	15	17	1K
3	Health Sciences	8	8	723
4	Public Health	3	3	83
5	Business	1	1	36

James J. Lah

199

Publications

22.5K

Citations

H-Index

Page 1

	Year	Citations
Variant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease Thorlákur Jónsson, Hreinn Stefánsson, Stacy Steinberg, New England Journal of Medicine	2012	2.5K
Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation Erik C. B. Johnson, Eric B. Dammer, Duc M. Duong, Nature Medicine Neuroimaging BiomarkersNeurodegenerative DiseasesAlzheimer's DiseaseMedicineBrain-immune Interaction	2020	993
The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease Minghui Wang, Noam D. Beckmann, Panos Roussos, Scientific Data	2018	580
Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level Erik C. B. Johnson, Kathleen Carter, Eric B. Dammer, Nature Neuroscience	2022	574
A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease Nicholas T. Seyfried, Eric B. Dammer, Vivek Swarup, Cell Systems Neuroimaging BiomarkersNeurodegenerative DiseasesMolecular NeuroscienceAlzheimer's DiseaseMedicine	2016	511
Evidence for brain glucose dysregulation in Alzheimer's disease Yang An, Vijay R. Varma, Sudhir Varma, Alzheimer s & Dementia	2017	492
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study Eric M. Reiman, Joseph F. Arboleda‐Velásquez, Yakeel T. Quiroz, Nature Communications	2020	464
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease Srikant Rangaraju, Eric B. Dammer, Syed Ali Raza, Molecular Neurodegeneration	2018	445
Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis Aliza P. Wingo, Yue Liu, Ekaterina S. Gerasimov, Nature Genetics Proteomic TechnologyNeurodegenerative DiseasesAlzheimer's DiseaseMedicineDegenerative Pathology	2021	380
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease Lenora Higginbotham, Lingyan Ping, Eric B. Dammer, Science Advances Csf Ad MarkersProteomic TechnologyNeurodegenerative DiseasesNeuroimaging BiomarkersAlzheimer's Disease	2020	377

Page 1